Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28804599)

Published in J Extracell Vesicles on July 12, 2017

Authors

Vicky K Yang1, Kerry A Loughran1, Dawn M Meola1, Christine M Juhr1, Kristen E Thane1, Airiel M Davis1, Andrew M Hoffman1

Author Affiliations

1: Department of Clinics Sciences, Tufts University Cummings School of Veterinary Medicine, North Grafton, USA.

Articles cited by this

TM4: a free, open-source system for microarray data management and analysis. Biotechniques (2003) 38.02

Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol (2014) 7.41

2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol (2008) 5.99

MicroRNA profiling: approaches and considerations. Nat Rev Genet (2012) 4.39

Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov (2013) 4.35

Predicting effective microRNA target sites in mammalian mRNAs. Elife (2015) 4.30

Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles (2013) 4.05

Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol (2014) 3.97

A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature (1995) 2.98

miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res (2014) 2.36

Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med (2009) 2.06

Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res (2012) 1.95

Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J Thromb Haemost (2014) 1.90

miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion (2011) 1.85

miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling. Cell Metab (2015) 1.85

The mitochondrial RNA-binding protein GRSF1 localizes to RNA granules and is required for posttranscriptional mitochondrial gene expression. Cell Metab (2013) 1.56

Modulation of transforming growth factor-β signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers. Circulation (2012) 1.19

The SLC8 gene family of sodium-calcium exchangers (NCX) - structure, function, and regulation in health and disease. Mol Aspects Med (2013) 1.17

TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves. Cardiovasc Res (2013) 1.04

Solid tumors of childhood display specific serum microRNA profiles. Cancer Epidemiol Biomarkers Prev (2014) 0.99

MicroRNA-181c targets Bcl-2 and regulates mitochondrial morphology in myocardial cells. J Cell Mol Med (2015) 0.90

Historical review, epidemiology and natural history of degenerative mitral valve disease. J Vet Cardiol (2012) 0.90

miR-599 Inhibits Vascular Smooth Muscle Cells Proliferation and Migration by Targeting TGFB2. PLoS One (2015) 0.87

MicroRNA profiling of atrial fibrillation in canines: miR-206 modulates intrinsic cardiac autonomic nerve remodeling by regulating SOD1. PLoS One (2015) 0.85

Immunohistochemical characterization of the extracellular matrix in normal mitral valves and in chronic valve disease (endocardiosis) in dogs. Res Vet Sci (2009) 0.84

Cardiac Myocyte KLF5 Regulates Ppara Expression and Cardiac Function. Circ Res (2015) 0.84

miR-181c regulates the mitochondrial genome, bioenergetics, and propensity for heart failure in vivo. PLoS One (2014) 0.84

Expression of transforming growth factor-beta1, -beta2 and -beta3 in normal and diseased canine mitral valves. J Comp Pathol (2008) 0.83

MicroRNAs in the Myocyte Enhancer Factor 2 (MEF2)-regulated Gtl2-Dio3 Noncoding RNA Locus Promote Cardiomyocyte Proliferation by Targeting the Transcriptional Coactivator Cited2. J Biol Chem (2015) 0.83

Roles of exosomes in cardioprotection. Eur Heart J (2017) 0.81

miRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis. Nucleic Acids Res (2016) 0.80

Plasma miRNAs as potential biomarkers of chronic degenerative valvular disease in Dachshunds. BMC Vet Res (2014) 0.79

Novel insights into TRPM7 function in fibrotic diseases: a potential therapeutic target. J Cell Physiol (2015) 0.79

Detailed characterization of microRNA changes in a canine heart failure model: Relationship to arrhythmogenic structural remodeling. J Mol Cell Cardiol (2014) 0.79

Akt-dependent Girdin phosphorylation regulates repair processes after acute myocardial infarction. J Mol Cell Cardiol (2015) 0.78

MicroRNA-9 regulates cardiac fibrosis by targeting PDGFR-β in rats. J Physiol Biochem (2016) 0.77

Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling. Cardiovasc Res (2016) 0.77

Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease. Int J Mol Sci (2015) 0.76

miR-410 and miR-495 Are Dynamically Regulated in Diverse Cardiomyopathies and Their Inhibition Attenuates Pathological Hypertrophy. PLoS One (2016) 0.75

Gene signatures of postoperative atrial fibrillation in atrial tissue after coronary artery bypass grafting surgery in patients receiving β-blockers. J Mol Cell Cardiol (2016) 0.75